{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T10:56:33Z","timestamp":1769338593735,"version":"3.49.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"33","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1097\/md.0000000000004483","type":"journal-article","created":{"date-parts":[[2016,8,18]],"date-time":"2016-08-18T16:03:29Z","timestamp":1471536209000},"page":"e4483","source":"Crossref","is-referenced-by-count":8,"title":["Hepatic fibrosis and immune phenotype vary by HCV viremia in HCV\/HIV co-infected subjects"],"prefix":"10.1097","volume":"95","author":[{"given":"Seema N.","family":"Desai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L.","family":"Dodge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan L.","family":"Landay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marshall J.","family":"Glesby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia S.","family":"Latham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria C.","family":"Villacres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey L.","family":"French","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Gange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth M.","family":"Greenblatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion G.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-21-20210309","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"Mohd Hanafiah","year":"2013","journal-title":"Hepatology"},{"key":"R2-21-20210309","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1478-3231.2011.02494.x","article-title":"Hepatitis C virus infection in USA: an estimate of true prevalence","volume":"31","author":"Chak","year":"2011","journal-title":"Liver Int"},{"key":"R3-21-20210309","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3748\/wjg.v8.i4.577","article-title":"Hepatitis C and HIV co-infection: a review","volume":"8","author":"Maier","year":"2002","journal-title":"World J Gastroenterol"},{"key":"R4-21-20210309","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ije\/dyh307","article-title":"Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS","volume":"34","author":"Lewden","year":"2005","journal-title":"Int J Epidemiol"},{"key":"R5-21-20210309","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1473-3099(05)70216-4","article-title":"Global epidemiology of hepatitis C virus infection","volume":"5","author":"Shepard","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"R6-21-20210309","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"Diagnosis, management, and treatment of hepatitis C: an update","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology"},{"key":"R7-21-20210309","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1086\/429489","article-title":"Coinfection with HIV and hepatitis C virus in injection drug users and minority populations","volume":"41","author":"Strader","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R8-21-20210309","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1182\/blood-2003-09-3333","article-title":"Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load","volume":"104","author":"Deeks","year":"2004","journal-title":"Blood"},{"key":"R9-21-20210309","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1097\/00002030-200309050-00006","article-title":"Persistent immune activation in HIV-1 infection is associated with progression to AIDS","volume":"17","author":"Hazenberg","year":"2003","journal-title":"Aids"},{"key":"R10-21-20210309","doi-asserted-by":"crossref","first-page":"11407","DOI":"10.1128\/JVI.01211-09","article-title":"High levels of chronic immune activation in the T-cell compartments of patients coinfected with hepatitis C virus and human immunodeficiency virus type 1 and on highly active antiretroviral therapy are reverted by alpha interferon and ribavirin treatment","volume":"83","author":"Gonzalez","year":"2009","journal-title":"J Virol"},{"key":"R11-21-20210309","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/QAI.0b013e31829c6de0","article-title":"Characterization of CD4(+) T-cell immune activation and interleukin 10 levels among HIV, hepatitis C virus, and HIV\/HCV-coinfected patients","volume":"64","author":"Hodowanec","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R12-21-20210309","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1182\/blood-2004-06-2336","article-title":"The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1","volume":"105","author":"Kim","year":"2005","journal-title":"Blood"},{"key":"R13-21-20210309","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1136\/gutjnl-2011-300620","article-title":"T cell responses in hepatitis C: the good, the bad and the unconventional","volume":"61","author":"Klenerman","year":"2012","journal-title":"Gut"},{"key":"R14-21-20210309","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1189\/jlb.4RI0214-126R","article-title":"Immune control and failure in HCV infection\u2013tipping the balance","volume":"96","author":"Dustin","year":"2014","journal-title":"J Leukoc Biol"},{"key":"R15-21-20210309","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00001648-199803000-00004","article-title":"The Women's Interagency HIV Study. WIHS Collaborative Study Group","volume":"9","author":"Barkan","year":"1998","journal-title":"Epidemiology"},{"key":"R16-21-20210309","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"R17-21-20210309","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"R18-21-20210309","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/QAD.0b013e32834fa121","article-title":"Assessing mortality in women with hepatitis C virus and HIV using indirect markers of fibrosis","volume":"26","author":"Bambha","year":"2012","journal-title":"AIDS"},{"key":"R19-21-20210309","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/hep.510300409","article-title":"Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group","volume":"30","author":"Benhamou","year":"1999","journal-title":"Hepatology"},{"key":"R20-21-20210309","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jhep.2005.07.006","article-title":"Slower fibrosis progression in HIV\/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy","volume":"44","author":"Brau","year":"2006","journal-title":"J Hepatol"},{"key":"R21-21-20210309","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.cgh.2010.08.004","article-title":"Similar progression of fibrosis between HIV\/HCV-infected and HCV-infected patients: Analysis of paired liver biopsy samples","volume":"8","author":"Sterling","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R22-21-20210309","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/S0140-6736(00)03232-3","article-title":"Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study","volume":"356","author":"Greub","year":"2000","journal-title":"Lancet"},{"key":"R23-21-20210309","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1097\/QAD.0b013e32833a2a32","article-title":"Hepatitis C infection in HIV-1 natural viral suppressors","volume":"24","author":"Sajadi","year":"2010","journal-title":"AIDS"},{"key":"R24-21-20210309","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/QAI.0000000000000310","article-title":"Association of chronic hepatitis C infection with T-cell phenotypes in HIV-negative and HIV-positive women","volume":"67","author":"Kuniholm","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R25-21-20210309","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1097\/QAD.0000000000000418","article-title":"Influence of hepatitis C virus coinfection on CD4(+) T cells of HIV-infected patients receiving HAART","volume":"28","author":"Shmagel","year":"2014","journal-title":"AIDS"},{"key":"R26-21-20210309","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/infdis\/jiq101","article-title":"Reduced naive CD4 T cell numbers and impaired induction of CD27 in response to T cell receptor stimulation reflect a state of immune activation in chronic hepatitis C virus infection","volume":"203","author":"Yonkers","year":"2011","journal-title":"J Infect Dis"},{"key":"R27-21-20210309","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1086\/314660","article-title":"Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage","volume":"179","author":"Giorgi","year":"1999","journal-title":"J Infect Dis"},{"key":"R28-21-20210309","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1182\/blood.V96.9.2951","article-title":"Mechanisms of HIV-associated lymphocyte apoptosis","volume":"96","author":"Badley","year":"2000","journal-title":"Blood"},{"key":"R29-21-20210309","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1086\/587696","article-title":"CD8(+) T cell activation in women coinfected with human immunodeficiency virus type 1 and hepatitis C virus","volume":"197","author":"Kovacs","year":"2008","journal-title":"J Infect Dis"},{"key":"R30-21-20210309","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1089\/aid.2011.0318","article-title":"HCV coinfection does not alter the frequency of regulatory T cells or CD8+ T cell immune activation in chronically infected HIV+ Chinese subjects","volume":"28","author":"Zhuang","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R31-21-20210309","doi-asserted-by":"crossref","first-page":"e30306","DOI":"10.1371\/journal.pone.0030306","article-title":"Interferon-alpha administration enhances CD8+ T cell activation in HIV infection","volume":"7","author":"Manion","year":"2012","journal-title":"PLoS One"},{"key":"R32-21-20210309","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1086\/508355","article-title":"Coinfection with hepatitis C virus increases lymphocyte apoptosis in HIV-infected patients","volume":"43","author":"Nunez","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R33-21-20210309","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1042\/CS20080532","article-title":"Effects of HCV co-infection on apoptosis of CD4+ T-cells in HIV-positive patients","volume":"116","author":"Korner","year":"2009","journal-title":"Clin Sci (Lond"},{"key":"R34-21-20210309","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/QAI.0b013e3181cbd469","article-title":"Elevated caspase-3 expression and T-cell activation in elite suppressors","volume":"54","author":"Ronquillo","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R35-21-20210309","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/135965350400900116","article-title":"Suppression of hepatitis C virus replication is maintained long term following HAART therapy, in an individual with HCV\/HIV co-infection","volume":"9","author":"Torti","year":"2004","journal-title":"Antivir Ther"},{"key":"R36-21-20210309","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jcv.2007.05.014","article-title":"Stable recovery from HCV in HIV-HCV co-infection under antiretroviral therapy","volume":"40","author":"Zeitoun","year":"2007","journal-title":"J Clin Virol"},{"key":"R37-21-20210309","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/jmv.21489","article-title":"Case report: clearance of hepatitis C virus after changing the HAART regimen in a patient infected with hepatitis C virus and the human immunodeficiency virus","volume":"81","author":"Endo","year":"2009","journal-title":"J Med Virol"},{"key":"R38-21-20210309","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0167-5699(94)90220-8","article-title":"The Th1-Th2 hypothesis of HIV infection: new insights","volume":"15","author":"Clerici","year":"1994","journal-title":"Immunol Today"},{"key":"R39-21-20210309","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/75063","article-title":"Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C","volume":"6","author":"Takaki","year":"2000","journal-title":"Nat Med"},{"key":"R40-21-20210309","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/hep.26128","article-title":"Hepatitis C virus promotes T-helper (Th)17 responses through thymic stromal lymphopoietin production by infected hepatocytes","volume":"57","author":"Lee","year":"2013","journal-title":"Hepatology"},{"key":"R41-21-20210309","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/hep.23273","article-title":"Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B","volume":"51","author":"Zhang","year":"2010","journal-title":"Hepatology"},{"key":"R42-21-20210309","doi-asserted-by":"crossref","first-page":"e20104","DOI":"10.1371\/journal.pone.0020104","article-title":"Progression of biopsy-measured liver fibrosis in untreated patients with hepatitis C infection: non-Markov multistate model analysis","volume":"6","author":"Bacchetti","year":"2011","journal-title":"PLoS One"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000004483","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T05:42:55Z","timestamp":1657086175000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201608160-00021"}},"subtitle":["A Women's interagency HIV study"],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":42,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000004483","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]}}}